| Price | 550.00p on 27-02-2026 at 19:15:06 |
|---|---|
| Change | 0.00p 0% |
| Buy | 580.00p |
| Sell | 520.00p |
| Last Trade: | Buy 2.00 at 557.40p |
| Day's Volume: | 19 |
| Last Close: | 550.00p |
| Open: | 550.00p |
| ISIN: | GB00BMCLYF79 |
| Day's Range | 550.00p - 550.00p |
| 52wk Range: | 550.00p - 1,200.00p |
| Market Capitalisation: | £85.17m |
| VWAP: | 556.14737p |
| Shares in Issue: | 15.48m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
4basebio Plc (4BB) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 2 | 557.40p | Ordinary |
09:16:59 - 27-Feb-26 |
| Buy* | 17 | 556.00p | Ordinary |
08:32:18 - 27-Feb-26 |
| Sell* | 69 | 521.00p | Ordinary |
09:01:01 - 26-Feb-26 |
| Unknown* | 485 | 550.00p | Ordinary |
16:08:51 - 25-Feb-26 |
| Unknown* | 285 | 550.00p | Ordinary |
16:08:51 - 25-Feb-26 |
| Unknown* | -485 | 550.00p | Ordinary Correction |
16:08:51 - 25-Feb-26 |
| Buy* | 5 | 557.40p | Ordinary |
11:00:57 - 25-Feb-26 |
| Unknown* | 200 | 550.00p | Uncrossing Trade |
09:00:16 - 25-Feb-26 |
| Unknown* | 2,500 | 550.00p | Negotiated Trade |
14:21:29 - 24-Feb-26 |
| Sell* | 952 | 526.60p | Ordinary |
14:19:57 - 24-Feb-26 |
4basebio Plc (4BB) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 16th Feb 2026 7:00 am | PRN | Director Dealing |
| 11th Feb 2026 3:58 pm | PRN | Director Dealing |
| 10th Feb 2026 7:00 am | PRN | Leadership Changes |
| 27th Oct 2025 7:00 am | PRN | Synthetic opDNA® utilised in Phase I/II US clinical trials |
| 10th Oct 2025 11:30 am | PRN | Result of Extraordinary General Meeting |
| 30th Sep 2025 4:20 pm | PRN | Director Dealing |
| 29th Sep 2025 7:00 am | PRN | Half-year Report |
| 22nd Jul 2025 7:00 am | PRN | Employee Long Term Incentive Plan and Issue of Equity |
| 8th Jul 2025 10:30 am | PRN | Director Appointment, Board Change |
| 3rd Jul 2025 7:00 am | PRN | Holding(s) in Company |
